These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 8883149)
21. SCID-Hu mouse as a model for human lung HIV-1 infection. Cesbron JY; Agut H; Gosselin B; Candotti D; Raphaël M; Puech F; Grandadam M; Debré P; Capron A; Autran B C R Acad Sci III; 1994 Jul; 317(7):669-74. PubMed ID: 7882151 [TBL] [Abstract][Full Text] [Related]
22. Human T-cell lymphotropic virus type-I infection in the severe combined immunodeficiency mouse. Furlan R; Salazar-Grueso EF; Martino G; Roos RP; Brambilla E; Castellano M; Cao J; Lillo F; Terreni MR; Bacellar H; Dorigatti F; Grimaldi LM J Med Virol; 1996 Jun; 49(2):77-82. PubMed ID: 8991939 [TBL] [Abstract][Full Text] [Related]
23. [Development of HPV16 positive cervical cancer model in the hu-PBL-SCID mouse and its immunological features]. Liang ZX; Cheng Q; Chen HZ; Xie X; Ye DF Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1465-9. PubMed ID: 15500747 [TBL] [Abstract][Full Text] [Related]
24. Porcine cell microchimerism but lack of productive porcine endogenous retrovirus (PERV) infection in naive and humanized SCID-beige mice treated with porcine peripheral blood mononuclear cells. Kuddus RH; Metes DM; Nalesnik MA; Logar AJ; Rao AS; Fung JJ Transpl Immunol; 2004; 13(1):15-24. PubMed ID: 15203124 [TBL] [Abstract][Full Text] [Related]
25. The anti-human tumor effect and generation of human cytotoxic T cells in SCID mice given human peripheral blood lymphocytes by the in vivo transfer of the Interleukin-6 gene using adenovirus vector. Tanaka F; Abe M; Akiyoshi T; Nomura T; Sugimachi K; Kishimoto T; Suzuki T; Okada M Cancer Res; 1997 Apr; 57(7):1335-43. PubMed ID: 9102222 [TBL] [Abstract][Full Text] [Related]
26. Human immunoglobulins produced in hu-PBL-SCID mice are polyclonal early after xenotransplantation. Tissot JD; Schneider P; Schapira M; Duchosal MA Cell Immunol; 1996 Feb; 167(2):241-8. PubMed ID: 8603433 [TBL] [Abstract][Full Text] [Related]
27. Mature human hematopoietic cells in donor bone marrow complicate interpretation of stem/progenitor cell assays in xenogeneic hematopoietic chimeras. Ramírez M; Rottman GA; Shultz LD; Civin CI Exp Hematol; 1998 Apr; 26(4):332-44. PubMed ID: 9546317 [TBL] [Abstract][Full Text] [Related]
28. Combination immunotherapy of B-cell non-Hodgkin's lymphoma with rituximab and interleukin-2: a preclinical and phase I study. Eisenbeis CF; Grainger A; Fischer B; Baiocchi RA; Carrodeguas L; Roychowdhury S; Chen L; Banks AL; Davis T; Young D; Kelbick N; Stephens J; Byrd JC; Grever MR; Caligiuri MA; Porcu P Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6101-10. PubMed ID: 15447996 [TBL] [Abstract][Full Text] [Related]
29. SCID-hu-PBL: a model for making human antibodies? Ifversen P; Borrebaeck CA Semin Immunol; 1996 Aug; 8(4):243-8. PubMed ID: 8883147 [TBL] [Abstract][Full Text] [Related]
30. Primary Th1 cell immunization against HIVgp160 in SCID-hu mice coengrafted with peripheral blood lymphocytes and skin. Delhem N; Hadida F; Gorochov G; Carpentier F; de Cavel JP; Andréani JF; Autran B; Cesbron JY J Immunol; 1998 Aug; 161(4):2060-9. PubMed ID: 9712080 [TBL] [Abstract][Full Text] [Related]
31. [Molecular pathological characteristics of human B-cell lymphomas induced by Epstein-Barr virus]. Gan RL; Yin ZH; Liu TF; Dong BH; Zhou JG; Yao KT Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):925-9. PubMed ID: 14515211 [TBL] [Abstract][Full Text] [Related]
32. Human immunoglobulin preparations suppress the occurrence of Epstein-Barr virus-associated lymphoproliferation. Nadal D; Guzman J; Fröhlich S; Braun DG Exp Hematol; 1997 Mar; 25(3):223-31. PubMed ID: 9091298 [TBL] [Abstract][Full Text] [Related]
33. Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies. Westphal EM; Blackstock W; Feng W; Israel B; Kenney SC Cancer Res; 2000 Oct; 60(20):5781-8. PubMed ID: 11059774 [TBL] [Abstract][Full Text] [Related]
34. Time-dependent induction of protective anti-influenza immune responses in human peripheral blood lymphocyte/SCID mice. Albert SE; McKerlie C; Pester A; Edgell BJ; Carlyle J; Petric M; Chamberlain JW J Immunol; 1997 Aug; 159(3):1393-403. PubMed ID: 9233636 [TBL] [Abstract][Full Text] [Related]
35. The human immune system in hu-PBL-SCID mice. Tary-Lehmann M; Saxon A; Lehmann PV Immunol Today; 1995 Nov; 16(11):529-33. PubMed ID: 7495490 [TBL] [Abstract][Full Text] [Related]
37. T-cell dysfunctions in hu-PBL-SCID mice infected with human immunodeficiency virus (HIV) shortly after reconstitution: in vivo effects of HIV on highly activated human immune cells. Rizza P; Santini SM; Logozzi MA; Lapenta C; Sestili P; Gherardi G; Lande R; Spada M; Parlato S; Belardelli F; Fais S J Virol; 1996 Nov; 70(11):7958-64. PubMed ID: 8892919 [TBL] [Abstract][Full Text] [Related]
38. In SCID-hu mice, passive transfer of a humanized antibody prevents infection and atrophic change of medulla in human thymic implant due to intravenous inoculation of primary HIV-1 isolate. Okamoto Y; Eda Y; Ogura A; Shibata S; Amagai T; Katsura Y; Asano T; Kimachi K; Makizumi K; Honda M J Immunol; 1998 Jan; 160(1):69-76. PubMed ID: 9551957 [TBL] [Abstract][Full Text] [Related]
39. The hu-PBL-SCID mouse in human lymphocyte function and lymphomagenesis studies: achievements and caveats. Amadori A; Veronesi A; Coppola V; Indraccolo S; Mion M; Chieco-Bianchi L Semin Immunol; 1996 Aug; 8(4):249-54. PubMed ID: 8883148 [TBL] [Abstract][Full Text] [Related]
40. A mouse monoclonal antibody against Epstein-Barr virus envelope glycoprotein 350 prevents infection both in vitro and in vivo. Haque T; Johannessen I; Dombagoda D; Sengupta C; Burns DM; Bird P; Hale G; Mieli-Vergani G; Crawford DH J Infect Dis; 2006 Sep; 194(5):584-7. PubMed ID: 16897655 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]